June 16, 2020
June 16, 2020 —
SDSC's Sherlock Division has expanded its multi-Cloud solution, Sherlock Cloud, to include the Google Cloud Platform (GCP) in addition to AWS and Microsoft Azure.
June 16, 2020
June 16, 2020 —
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
June 15, 2020
June 15, 2020 —
Researchers at UC San Diego School of Medicine, with colleagues elsewhere, will receive almost $19 million over five years for the fourth phase of the Vietnam Era Twin Study of Aging, which investigates cognition, aging and the risk for mild cognitive impairment and Alzheimer’s disease.
June 11, 2020
June 11, 2020 —
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
June 1, 2020
June 1, 2020 —
What happens in the hippocampus even before people attempt to form memories may impact whether they remember. Study suggests ‘encoding mode’ may play an important role in memory formation.
June 1, 2020
June 1, 2020 —
The National Science Foundation awards two SDSC researchers funding to organize COVID-19 information into a knowledge network that integrates health, pathogen, and environmental data to track cases across greater San Diego.
May 26, 2020
May 26, 2020 —
UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
May 19, 2020
May 19, 2020 —
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.
May 15, 2020
May 15, 2020 —
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
May 14, 2020
May 14, 2020 —
Using supercomputers, scientists have developed for the first time a way to screen drugs through their chemical structures for induced arrhythmias.
